Members: Carly Bridge

Carly Bridge, ND
Research Scientist
Mary Gates Research Scholar 2003

Curriculum Vitae

Dr. Carly Bridge originally joined the lab in 2001 as Dr. Swanson’s first student researcher. She spent three years working alongside Kristin and Buster in a one room office as she pursued her undergraduate degree in Neurobiology. Following graduation, she chose to attend Bastyr University for her formal medical training and received her Doctorate in Naturopathic Medicine in 2009. She then completed a nationally accredited Family Practice residency affiliated through the Bastyr Center for Natural Health. During her residency she continued pursuing her interests in teaching and research and ultimately felt the calling to return to academia.

ARTICLES–PEER REVIEWED:
  • K. R. Swanson, C. Bridge, J. D. Murray, E. C. Alvord Jr.: Virtual and Real Brain Tumors: Using Mathematical Modeling to Quantify Glioma Growth and Invasion. Journal of the Neurological Sciences, 216(1):1-10, 2003.  Pubmed ID: 14607296 PDF
  • Standish LJ, Sweet ES, Novack J, Wenner CA, C. Bridge, Nelson A, Martzen M, Torkelson C.: Breast cancer and the immune system. Journal of the Society for Integrative Oncology, 6(4):158-68, 2008.  Free PMC Article
  • Standish LJ, Wenner CA, Sweet ES, C. Bridge, Nelson A, Martzen M, Novack J, Torkelson C.:Trametes versicolor Mushroom Immune Therapy in Breast Cancer. Journal for the Society for Integrative Oncology, 6(3) 122-128, 2008.  Free PMC Article
  • Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, A.Baldock, C.A. Bridge, et al. Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric. PLoS ONE 8(1): e51951. doi:10.1371/journal.pone.0051951
  • M.L. Neal, A.D. Trister, S. Ahn,C.A. Bridge, L. Guyman, J. Lange, A. Baldock, R. Rockne, M. Mrugala, J.K. Rockhill, A. Lai, T. Cloughesy, K.R. Swanson. Response classification based on a minimal model of glioblastoma growth is a prognostic factor for time to progression and survival. Cancer Research; 73(10) 2976-2986, 2013.
  • A. Baldock, R. Rockne, A. Boone, M. Neal, A. Hawkins-Daarud, C.A. Bridge, L. Guyman, A. D. Trister, M. Mrugala, J. K. Rockhill, K. R. Swanson. From Patient-Specific Mathematical Neuro-Oncology to Precision Medicine. Frontiers in Molecular and Cellular Oncology; 3: 62. Published online 2013 April 2. Prepublished online 2013 January 11. doi: 10.3389/fonc.2013.00062
ABSTRACTS:
  • C. A. Bridge, E. C. Alvord Jr., K. R. Swanson. “ Validation of a Mathematical Model for Brain Tumor Growth and Invasion: Serial Followup of an Untreated Glioma”, American Association for the Advancement of Science (Seattle, WA), February 2004
  • K. R. Swanson, H. Harpold, S. Nissen, C.A. Bridge, A. Lai, T. Cloughesy, E. C. Alvord, Jr. Monitoring the Effects of Treatment in Glioblastomas: Integrating Mathematical Modeling with Clinical Imaging. Society for Neuro-Oncology (Toronto, Canada), November 2004 -Neuro-Oncology, 6(4):369, 2004
  • A. Trister, B. Bot, A. Hawkins-Daarud, K. Fontes, C.A. Bridge, J. K. Rockhill, M. Mrugala, R. Rockne, E. Huang, K. R. Swanson. A novel patient-specific model of glioma growth kinetics elucidates underlying biology as measured by gene expression microarray. Markers in Cancer, October 11-13, 2012 (Hollywood, FL)
  • M.L. Neal, A.D. Trister, S. Ahn, C.A. Bridge, J. Lange, A. Baldock, R. Rockne, M. Mrugala, J.K. Rockhill, A. Lai, T. Cloughesy, K.R. Swanson. A response metric based on a minimal model of glioblastoma growth is prognostic for time to progression and overall survival. Society for Neuro-Oncology Annual Meeting, 2012 (Washington, DC).
  • S.K. Johnston, C.A. Bridge, R. Rockne, L. Guyman, A. Baldock, J. K. Rockhill, M. Mrugala, S. Adair, H-PP. Kiem, K. R. Swanson. Enabling the Detection of Treatment Benefit in Novel Therapeutic Studies through Patient-Specific Mathematical Modeling: Analysis of Chemoprotective Hematopoietic Stem Cell Gene Therapy in Human Glioblastomas. Annual Meeting of the Society for Neuro-Oncology, 2012 (Washington, DC)
  • A. Hawkins-Daarud, A. Baldock, C.A. Bridge, D. Corwin, J. Rockhill, M. Mrugala, R. Rockne, K. R. Swanson. Revealing the diffuse extent of gliomas to enable surgical and radiotherapy treatment design: Insights from a Patient-Specific Mathematical Model and an Untreated Glioblastoma. Annual Meeting of the Society for Neuro-Oncology, 2012 (Washington, DC)
  • A. Trister, B. Bot, K. Fontes, C. A. Bridge, J. K. Rockhill, M. Mrugala, R. Rockne, E. Huang, K. R. Swanson. A novel patient-specific model of glioma growth kinetics elucidates underlying biology as measured by gene expression microarray. Annual Meeting of the Society for Neuro-Oncology, 2012 (Washington, DC)
  • C.A. Bridge, A. Baldock, P. Kumthekar, P. Dilfer, S.K. Johnston, J.Jacobs, D. Corwin, L. Guyman, R. Rockne, A. Sonabend, M. Cloney, P. Canoll, K.R. Swanson “Characteristics of long-term survivors in glioblastoma” Annual Meeting of the Society for Neuro-Oncology, 2013 (San Francisco, CA)

Currently the Medical Science Liason Novocure, Inc